AXIAL SPONDYLOARTHRITIS
Clinical trials for AXIAL SPONDYLOARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new AXIAL SPONDYLOARTHRITIS trials appear
Sign up with your email to follow new studies for AXIAL SPONDYLOARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to ease back pain in genetic arthritis
Disease control Not yet recruitingThis study tests a new drug called Natrunix, given with standard care, for people with a type of arthritis that affects the spine and joints (axial spondyloarthritis). The trial includes 60 adults who have a specific genetic marker (HLA-B27) and active disease. The goal is to see…
Matched conditions: AXIAL SPONDYLOARTHRITIS
Phase: PHASE2 • Sponsor: XBiotech, Inc. • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New study: can acemetacin ease back pain in spondyloarthritis?
Symptom relief Not yet recruitingThis study looks at how well acemetacin, a nonsteroidal anti-inflammatory drug (NSAID), works for adults with active axial spondyloarthritis—a type of arthritis that mainly affects the spine. About 150 people aged 18 to 65 will take a daily 90 mg pill for 4 weeks. Researchers wil…
Matched conditions: AXIAL SPONDYLOARTHRITIS
Phase: PHASE4 • Sponsor: Chinese PLA General Hospital • Aim: Symptom relief
Last updated May 13, 2026 16:01 UTC